This content is machine translated Advanced breast carcinoma What’s new? With antibody-drug conjugates, checkpoint and CDK4/6 inhibitors, three drug classes were in the spotlight at this year’s European Society for Medical Oncology (ESMO) congress in advanced breast cancer. This is…
